OncoCyte Total Current Liabilities 2014-2025 | OCX
OncoCyte total current liabilities from 2014 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| OncoCyte Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $7 |
| 2023 | $7 |
| 2022 | $12 |
| 2021 | $14 |
| 2020 | $9 |
| 2019 | $4 |
| 2018 | $6 |
| 2017 | $4 |
| 2016 | $4 |
| 2015 | $2 |
| 2014 | $6 |
| 2013 | $5 |
| OncoCyte Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $10 |
| 2024-12-31 | $7 |
| 2024-09-30 | $9 |
| 2024-06-30 | $7 |
| 2024-03-31 | $8 |
| 2023-12-31 | $7 |
| 2023-09-30 | $8 |
| 2023-06-30 | $8 |
| 2023-03-31 | $9 |
| 2022-12-31 | $12 |
| 2022-09-30 | $13 |
| 2022-06-30 | $14 |
| 2022-03-31 | $14 |
| 2021-12-31 | $14 |
| 2021-09-30 | $13 |
| 2021-06-30 | $20 |
| 2021-03-31 | $10 |
| 2020-12-31 | $9 |
| 2020-09-30 | $9 |
| 2020-06-30 | $7 |
| 2020-03-31 | $7 |
| 2019-12-31 | $4 |
| 2019-09-30 | $3 |
| 2019-06-30 | $4 |
| 2019-03-31 | $3 |
| 2018-12-31 | $6 |
| 2018-09-30 | $5 |
| 2018-06-30 | $4 |
| 2018-03-31 | $5 |
| 2017-12-31 | $4 |
| 2017-09-30 | $5 |
| 2017-06-30 | $5 |
| 2017-03-31 | $5 |
| 2016-12-31 | $4 |
| 2016-09-30 | $4 |
| 2016-06-30 | $3 |
| 2016-03-31 | $3 |
| 2015-12-31 | $2 |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | $6 |
| 2013-12-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.084B | $0.002B |
| OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.181B | 25.92 |
| Elevance Health (ELV) | United States | $85.871B | 11.08 |
| CVS Health (CVS) | United States | $80.417B | 10.00 |
| Cencora (COR) | United States | $56.019B | 19.49 |
| Natera (NTRA) | United States | $22.833B | 0.00 |
| DiDi Global (DIDIY) | China | $22.168B | 33.64 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| Solventum (SOLV) | United States | $13.000B | 13.76 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.955B | 0.00 |
| CochLear (CHEOY) | Australia | $11.511B | 0.00 |
| ICON (ICLR) | Ireland | $11.274B | 10.48 |
| Revvity (RVTY) | United States | $10.891B | 18.74 |
| Doximity (DOCS) | United States | $10.250B | 47.45 |
| Viatris (VTRS) | United States | $10.082B | 3.46 |
| HealthEquity (HQY) | United States | $9.777B | 42.83 |
| Avantor (AVTR) | United States | $9.070B | 13.18 |
| Medpace Holdings (MEDP) | United States | $8.989B | 23.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.365B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.034B | 13.78 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| BrightSpring Health Services (BTSG) | United States | $4.109B | 38.03 |
| Bausch + Lomb (BLCO) | Canada | $4.068B | 23.98 |
| Sotera Health (SHC) | United States | $3.508B | 19.93 |
| Alignment Healthcare (ALHC) | United States | $3.031B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.955B | 38.43 |
| Concentras Parent (CON) | United States | $2.766B | 15.98 |
| Organon (OGN) | United States | $2.477B | 2.63 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| GeneDx Holdings (WGS) | United States | $2.066B | 79.55 |
| Premier (PINC) | United States | $1.908B | 14.48 |
| Progyny (PGNY) | United States | $1.826B | 40.19 |
| PACS (PACS) | United States | $1.550B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.432B | 28.64 |
| Teladoc Health (TDOC) | United States | $1.249B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.194B | 9.09 |
| Establishment Labs Holdings (ESTA) | $1.075B | 0.00 | |
| CareDx (CDNA) | United States | $1.075B | 16.78 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.907B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.768B | 7.19 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.753B | 11.41 |
| Embecta (EMBC) | United States | $0.608B | 4.09 |
| LifeMD (LFMD) | United States | $0.559B | 0.00 |
| Enhabit (EHAB) | United States | $0.538B | 44.25 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| SBC Medicals (SBC) | United States | $0.502B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.486B | 10.95 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.423B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.00 |
| KindlyMD (NAKA) | United States | $0.103B | 0.00 |
| So-Young (SY) | China | $0.097B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.073B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.046B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |